BUDA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.292
EU - Europa 130
AS - Asia 83
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.290
CN - Cina 80
IT - Italia 36
FI - Finlandia 26
DE - Germania 21
GB - Regno Unito 15
RU - Federazione Russa 12
SE - Svezia 10
UA - Ucraina 6
IN - India 3
CA - Canada 2
AU - Australia 1
EU - Europa 1
FR - Francia 1
IE - Irlanda 1
LU - Lussemburgo 1
NO - Norvegia 1
Totale 1.507
Salva come PNG Salva come JPEG
Città #
Fairfield 212
Chandler 164
Houston 131
Woodbridge 118
Ashburn 98
Cambridge 76
Ann Arbor 65
Seattle 62
Wilmington 54
Princeton 30
Beijing 26
Medford 24
San Diego 22
Des Moines 21
Jacksonville 16
Helsinki 15
Roxbury 15
Padova 13
New York 8
Nanjing 7
Boardman 6
London 6
Guangzhou 4
Hefei 4
Nanchang 4
San Jose 4
Zhengzhou 4
Haikou 3
Hebei 3
Jinan 3
Ogden 3
Pune 3
Redmond 3
Trapani 3
Changsha 2
Everett 2
Kharkiv 2
Kilburn 2
Lavis 2
Preston 2
Redwood City 2
Winnipeg 2
Aprilia 1
Chicago 1
Comerio 1
Dongguan 1
Dublin 1
Falkenstein 1
Flekkeroy 1
Fuzhou 1
Genova 1
Hangzhou 1
Hanover 1
Hounslow 1
Jiaxing 1
Jinhua 1
Lappeenranta 1
Los Angeles 1
Luxembourg 1
Melbourne 1
Miami 1
Mirano 1
Munich 1
Nanping 1
Norwalk 1
San Daniele del Friuli 1
Selvazzano Dentro 1
Shanghai 1
Shenyang 1
Taiyuan 1
Tampa 1
Tianjin 1
Vezzano sul Crostolo 1
Walnut 1
Washington 1
Wuhan 1
Totale 1.280
Salva come PNG Salva come JPEG
Nome #
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial 149
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis 128
Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa 122
TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn’s disease 105
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 103
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 82
Semiautomatic evaluation of crypt architecture and vessel morphology in confocal microendoscopy: Application to ulcerative colitis 74
Intestinal Surgery for Crohn's Disease: Predictors of Recovery, Complications and Health Related Quality of Life 69
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 58
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 55
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study 53
Expression in ileal mucosa and sub-epitelial myofibroblasts is correlated to a pro-fibrogenetic phenotype in patients with Crohn's disease 49
TAK1 Expression in Ileal Mucosa and Sub-Epithelial Myofibroblasts Is Correlated to a Pro-Fibrogenic Phenotype in Patients with Crohn's Disease 46
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 44
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr (EBV) infection 40
Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. 39
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre 39
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice 37
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients 33
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results from the SoCOVID-19 Survey 30
Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing? 29
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 29
Eosinophilic Esophagitis and Achalasia: Are We Putting All the Pieces Together? 24
Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature 24
Reply Letter to “Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes” 23
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 22
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? 14
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction 8
Biliary Tree Diagnostics: Advances in Endoscopic Imaging andand Tissue Sampling 6
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series 5
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 2
Totale 1.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.227
article - articoli 6.991
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201959 0 0 0 0 0 0 0 0 0 0 30 29
2019/2020203 26 8 2 10 17 12 19 24 40 18 23 4
2020/2021239 12 7 9 9 33 21 12 15 32 33 35 21
2021/2022404 21 50 32 28 42 22 16 41 26 12 41 73
2022/2023291 55 43 8 29 47 35 2 23 29 4 12 4
2023/2024142 4 30 31 17 8 23 13 2 10 4 0 0
Totale 1.541